[go: up one dir, main page]

MX2011013060A - Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. - Google Patents

Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.

Info

Publication number
MX2011013060A
MX2011013060A MX2011013060A MX2011013060A MX2011013060A MX 2011013060 A MX2011013060 A MX 2011013060A MX 2011013060 A MX2011013060 A MX 2011013060A MX 2011013060 A MX2011013060 A MX 2011013060A MX 2011013060 A MX2011013060 A MX 2011013060A
Authority
MX
Mexico
Prior art keywords
methods
manufacture
ophthalmic formulations
same
eye
Prior art date
Application number
MX2011013060A
Other languages
English (en)
Inventor
George Minno
George W Ousler Iii
Matthew Jonathan Chapin
Mark Barry Abelson
Jakie Nice
Original Assignee
Aciex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aciex Therapeutics Inc filed Critical Aciex Therapeutics Inc
Publication of MX2011013060A publication Critical patent/MX2011013060A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona composiciones para tratar y/o evitar signos y síntomas asociados con ojo seco y/o irritación ocular, y métodos de uso de las mismas. Tales composiciones se proporcionan en formulaciones oftálmicas novedosas que son cómodas con la colocación gota a gota en el ojo. También se proporcionan métodos de preparación.
MX2011013060A 2009-06-05 2010-06-04 Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. MX2011013060A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18443509P 2009-06-05 2009-06-05
PCT/US2010/037423 WO2010141831A1 (en) 2009-06-05 2010-06-04 Ophthalmic formulations, methods of manufacture, and methods of using same

Publications (1)

Publication Number Publication Date
MX2011013060A true MX2011013060A (es) 2012-02-28

Family

ID=43298181

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013060A MX2011013060A (es) 2009-06-05 2010-06-04 Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.

Country Status (6)

Country Link
US (1) US20100311688A1 (es)
EP (1) EP2437602A4 (es)
JP (1) JP2012528888A (es)
CA (1) CA2764477A1 (es)
MX (1) MX2011013060A (es)
WO (1) WO2010141831A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006504661A (ja) 2002-07-30 2006-02-09 オメロス コーポレイション 眼科学的洗浄溶液および眼科学的洗浄方法
BR112013001609A2 (pt) * 2010-07-22 2017-04-04 Merz Pharma Gmbh & Co Kgaa composição farmacêutica, processo para a preparação de uma composição farmacêutica, e, uso de um composto de ciclodextrina
ES2739490T3 (es) 2010-11-16 2020-01-31 Univ Leland Stanford Junior Sistemas para el tratamiento del ojo seco
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
CN103370087A (zh) * 2011-01-19 2013-10-23 目立康株式会社 隐形眼镜用液体制剂
US20120225918A1 (en) 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
KR102276326B1 (ko) 2013-03-13 2021-07-13 앙테이스 에스.아. 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법
CN105307718B (zh) 2013-04-19 2018-05-11 奥库利维公司 鼻刺激装置和方法
EP2999775A4 (en) * 2013-05-23 2016-06-08 Smm Ventures Llc SKLERALLINSENSLÖSUNG
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US9687652B2 (en) 2014-07-25 2017-06-27 Oculeve, Inc. Stimulation patterns for treating dry eye
WO2016013993A1 (en) * 2014-07-25 2016-01-28 Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. Stable preservative free ophthalmic formulations of opioid antagonists
EP3721938A1 (en) 2014-10-22 2020-10-14 Oculeve, Inc. Stimulation devices and methods for treating dry eye
EP3209370A4 (en) 2014-10-22 2018-05-30 Oculeve, Inc. Contact lens for increasing tear production
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
AU2017260237A1 (en) 2016-05-02 2018-11-22 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
CN113244291A (zh) 2016-08-19 2021-08-13 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物
CA3045018A1 (en) * 2016-12-02 2018-06-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation
WO2018156501A1 (en) * 2017-02-21 2018-08-30 Tearsolutions, Inc. Stable peptide compositions
US20180353504A1 (en) * 2017-06-08 2018-12-13 Eye Therapies, Llc Low-dose brimonidine combinations and uses thereof
US20190374537A1 (en) * 2018-06-07 2019-12-12 Eye Therapies, Llc Low-dose brimonidine combinations and uses thereof
CN114376961A (zh) 2017-08-18 2022-04-22 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法和用于治疗人类眼睛的组合物
US10799481B1 (en) * 2019-05-06 2020-10-13 Rvl Pharmaceuticals, Inc. Compositions and methods for treating ocular disorders
HUP1900450A1 (hu) * 2019-12-23 2021-06-28 Univ Szegedi Eljárás Alzheimer-kór spektrumába tartozó neurokognitív zavarok diagnosztizálására könnymintából, valamint az eljárásban alkalmazható oldat és diagnosztikai kit
CN113712907A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种盐酸左西替利嗪滴眼液组合物及其制备方法
EP4467144A4 (en) * 2022-01-21 2026-01-21 Senju Usa Inc AQUEOUS LIQUID FORMULATION

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096733A (en) * 1998-12-10 2000-08-01 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US7658947B2 (en) * 2004-06-25 2010-02-09 Kimberly-Clark Worldwide, Inc. Thermo-gelling composition
US20080039398A1 (en) * 2006-01-25 2008-02-14 Ousler George W Iii Formulations and methods for treating dry eye
WO2009035034A1 (ja) * 2007-09-14 2009-03-19 Rohto Pharmaceutical Co., Ltd. 眼科用組成物

Also Published As

Publication number Publication date
CA2764477A1 (en) 2010-12-09
EP2437602A4 (en) 2014-02-19
US20100311688A1 (en) 2010-12-09
EP2437602A1 (en) 2012-04-11
WO2010141831A1 (en) 2010-12-09
JP2012528888A (ja) 2012-11-15

Similar Documents

Publication Publication Date Title
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
EP4374851A3 (en) Ophthalmic composition for treatment of dry eye disease
MX2022000754A (es) Composiciones y metodos de uso de nintedanib para tratar enfermedades oculares con neovascularizacion anormal.
CA2883095C (en) Antibody and protein formulations
MX2011013061A (es) Formulaciones oftalmicas de fluticasona y metodos de uso.
PH12021550621A1 (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
CL2012003427A1 (es) Compuestos derivados de 5-amino-3,6-dihidro-1h-pirazina-2-ona; y uso en el tratamiento de enfermedades tales como alzheimer, senilidad, demencia, entre otras.
MY171920A (en) Prevention and treatment of ocular conditions
NZ704247A (en) Compositions and treatment for eye diseases and disorders
EP2166991A4 (en) HYDROGELS BASED ON PVA-PAA
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
EA200870396A1 (ru) Лечение аллергических заболеваний глаз
MX2013004061A (es) Analogos de ciclosporina.
WO2012119070A3 (en) Silicone-based ophthalmic formulations
MX390493B (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas
EP4410312A3 (en) Topical cyclosporine-containing formulations and uses thereof
WO2011116020A3 (en) Ophthalmic formulations of cetirizine and methods of use
MY178169A (en) Topical ophthalmic peptide formulation
CY1124538T1 (el) Χρηση prg4 για τη βελτιωση της δυναμικης οπτικης οξυτητας και εκτροπων υψηλοτερης ταξης
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
MY150931A (en) Substituted oxazolidinones and their use
MX2013004062A (es) Analogos de ciclosporina.
WO2007058935A3 (en) Ophthalmic composition for dry eye therapy
WO2018033941A3 (en) Pharmaceutical compositions of ibrutinib

Legal Events

Date Code Title Description
FA Abandonment or withdrawal